Last --
Change Today 0.00 / 0.00%
Volume 0.0
6869 On Other Exchanges
Symbol
Exchange
6869 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

sysmex corp (6869) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SYSMEX CORP (6869)

Related News

No related news articles were found.

sysmex corp (6869) Related Businessweek News

No Related Businessweek News Found

sysmex corp (6869) Details

Sysmex Corporation, together with its subsidiaries, engages in the research and development, production, sale, service, and support of diagnostic instruments, reagents, and software worldwide. The company provides diagnostics products for use in the areas of hematology, hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care testing; and laboratory information systems, including La-vietal LS, a clinical testing instrument system that links clinical testing instruments and other systems to provide an efficient operating environment. It also offers particle characterization analyzer products, including FPIA-3000 Flow Particle Image Analyzer, which offers automated analysis of particle size and shape; FPIA-3000 Darkfield unit to analyze samples, such as drugs, mica, and biological cells; and XT-2000iV, an animal blood cell analysis software used in the hematological analysis of laboratory veterinary animals, such as rats, mice, or dogs. In addition, the company provides life sciences solutions comprising automated gene amplification detector, a system for the detection of lymph node metastasis based on the one-step nucleic acid amplification method used for the diagnosis of breast, colon, and stomach cancer lymph node diagnosis in hospitals and other facilities, as well as a laboratory testing service for research involving the risk of recurrence of early-stage breast cancer. Further, it offers ASTRIM SU, a peripheral artery monitoring device that measures hemoglobin levels without blood sampling and is used in fitness centers and various other sites, as well as sells health management support software, which supports health check services at drug-stores and in the healthcare sections of other shops. The company was formerly known as TOA Medical Electronics Co., Ltd., and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

5,401 Employees
Last Reported Date: 06/20/14
Founded in 1968

sysmex corp (6869) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sysmex corp (6869) Key Developments

Sysmex Corp. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2014; Provides Earnings Guidance for the Six Months Ending September 30, 2014 and for the Full Year Ending March 31, 2015; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2015

Sysmex Corp. announced consolidated earnings results for the first quarter ended June 30, 2014. For the period, the company reported net sales of JPY 46,737 million against JPY 39,547 million a year ago. Operating income was JPY 8,763 million against JPY 4,780 million a year ago. Ordinary income was JPY 8,507 million against JPY 5,057 million a year ago. Net income was JPY 5,187 million or JPY 24.99 per diluted share against JPY 3,066 million or JPY 14.78 per diluted share a year ago. Net assets per share as on June 30, 2014 were JPY 706.02 against JPY 703.76 as on March 31, 2014. Net cash provided by operating activities was JPY 3,763 million compared to JPY 2,713 million a year ago. Purchase of property, plant and equipment was JPY 2,235 million compared to JPY 3,490 million a year ago. Purchase of intangible assets was JPY 810 million compared to JPY 621 million a year ago. Income before income taxes and minority interest was JPY 8,501 million against JPY 4,974 million a year ago. The company provided earnings guidance for the six months ending September 30, 2014 and for the full year ending March 31, 2015. For the six months ending September 30, 2014, the company expects net sales of JPY 100,000 million, operating income of JPY 16,000 million, ordinary income of JPY 16,000 million and net income of JPY 10,000 million or JPY 48.26 per share. For the year ending March 31, 2015, the company expects net sales of JPY 210,000 million, operating income of JPY 36,000 million, ordinary income of JPY 36,000 and net income of JPY 22,000 million or earnings per share of JPY 106.16. For the second quarter of fiscal 2015, the company expects to pay a dividend of JPY 14 per share against JPY 21.00 per share a year ago. For the full year ending March 31, 2015, the company expects to pay a year end dividend of JPY 14 per share compared to the dividend of JPY 33.00 per share paid in the previous year.

Sysmex Corp., Q1 2015 Earnings Call, Aug 06, 2014

Sysmex Corp., Q1 2015 Earnings Call, Aug 06, 2014

Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw to Executive Officer

Sysmex America Inc., the United States subsidiary for Sysmex Corporation announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of Sysmex Corporation. Kershaw's appointment marks the first time an executive from an overseas subsidiary has been appointed. As an Executive Officer, Kershaw will serve in a consultative capacity to the corporation's president and governing board while maintaining his leadership position with Sysmex America. As a result of Sysmex's strategic move to establish a new software products business in the United States and the requirement to lead an aggressive growth campaign in the Laboratory Diagnostics division of the company, Kershaw was transferred to America where he became Chief Operating Officer, Managing Director, and a Board Member of Sysmex's U.S. headquarters, Sysmex Corporation of America, now known as Sysmex America Inc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6869:JP ¥4,100.00 JPY +30.00

6869 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Rad Laboratories Inc $118.83 USD +0.76
BioMerieux €81.49 EUR +0.02
Mindray Medical International Ltd $31.21 USD +0.02
Nihon Kohden Corp ¥5,660 JPY -90.00
PerkinElmer Inc $44.35 USD +0.05
View Industry Companies
 

Industry Analysis

6869

Industry Average

Valuation 6869 Industry Range
Price/Earnings 34.8x
Price/Sales 4.1x
Price/Book 5.4x
Price/Cash Flow 30.8x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYSMEX CORP, please visit www.sysmex.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.